AveXis

About:

AveXis is a Biotech company is focused on developing gene therapy for patients with rare and life-threatening neurological genetic diseases.

Website: https://avexis.com/

Twitter/X: avexisinc

Top Investors: RA Capital Management, Deerfield, RTW Investments, Foresite Capital, Venrock

Description:

AveXis , doing business as Novartis Gene Therapies, Inc., is a biotechnology company that specializes in the development and commercialization of gene therapies for patients and families affected by rare and life-threatening neurological genetic diseases. AveXis was acquired by Novartis on May 14, 2018. In 2020, the company was renamed Novartis Gene Therapies.